Actinogen Medical Activates First Trial Site for Phase 2B Alzheimer's Disease Trial
Actinogen Medical Activates First Trial Site for Phase 2B Alzheimer's Disease Trial
Actinogen Medical 激活 2B 期阿爾茨海默氏病試驗的第一個試驗場地
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊